Lunch ON 2mg Tablet

The rapid onset and short duration of action of Repaglinide allow for flexible dosing with meals, minimizing the risk of prolonged hypoglycemia. Lunch ON 2mg Tablet should be taken shortly before meals, typically two to four times daily, to optimize post-meal glucose regulation. It is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or hypersensitivity to Repaglinide.

Common adverse effects include hypoglycemia, headache, and gastrointestinal disturbances such as nausea and diarrhea. Caution is advised in patients with hepatic or renal impairment, and dose adjustments may be necessary. Regular monitoring of blood glucose levels is essential to ensure therapeutic efficacy and safety. Lunch ON 2mg Tablet should be used as part of a comprehensive diabetes management plan including diet, exercise, and lifestyle modifications.